Inhibrx

0 followers


Anchored by our protein-engineering expertise and our proprietary single-domain antibody platform, we’ve developed a unique pipeline of therapeutic candidates.

Industries

Headquarters

Stage

Employees

Links

Org chart

Mark P. Lappe
Founder & CEO

Mark P. Lappe

Collapse
Brendan P. Eckelman
Chief Scientific Officer & EVP Corporate Strategy
Kelly Deck
EVP & CFO
Jeffrey Jensen
EVP & Chief Clinical Development Officer
Ashraf Amanullah
EVP & Chief Technical Operations Officer
David Matly
Evp, Chief Commercial And Business Development Officer
Leah Pollema
General Counsel
Carlos Bais
EVP, Translational Sciences
David Kao
VP, Regulatory Affairs
Vasily Andrianov
VP, Clinical Development & Medical Affairs
Dana Ebbets-Reed
VP, Quality Assurance
Darren Brown
VP, Analytical Development & Quality Control
Robert Boothroyd
VP, Medical Affairs & Business Development
Brian Lobo
VP, Formulation Development & Drug Product Manufacturing
Melissa Masterson
VP, Value, Access & Distribution